Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Pierre Fabre Medicament
Scripps Translational Science Institute
Roswell Park Cancer Institute
CHU de Reims
Wake Forest University Health Sciences
Columbia University
New York Medical College
Columbia University
National Institutes of Health Clinical Center (CC)